Status:
TERMINATED
A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Neuralgia, Postherpetic
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
The purpose of this Study is to test the Safety and Effectiveness of MK0686 in relieving neuropathic (chronic) pain as experienced by patients with Postherpetic Neuralgia (Also Know as PHN or Post Shi...
Eligibility Criteria
Inclusion
- Diagnosis of postherpetic neuralgia with pain having lasted at least 6 months
- Able to complete study questionnaires, patient diary, and comply with daily study medication
- Patient is not satisfied with current treatment for pain control
Exclusion
- Pregnant or nursing female
- History of evidence of a condition that in the opinion of the investigator, may interfere with the study results (e.g., diabetic neuropathy of fibromyalgia) or pose undue risk to undergo the course of medication required by the study (e.g., unstable heart disease, morbid obesity, kidney or liver disease)
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2006
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00282763
Start Date
December 1 2005
End Date
August 1 2006
Last Update
November 23 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.